GC Biopharma said Wednesday that it would transfer its US affiliate Curevo Vaccine to Eli Lilly and Company in a deal worth up to $1.5 billion. Under the agreem

The deals give Lilly vaccines targeting shingles, bacterial pathogens, and Epstein-Barr virus as it expands beyond weight loss drugs

Lilly is making three acquisitions at once on Tuesday, for up to $3.8 billion total, to increase its presence in infectious disease. The pharma is buying Curevo, LimmaTech…